Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05753410 · ClinicalTrials.gov registry record · NA
App-Based Mindfulness Training for Individuals With Anorexia Nervosa and Bulimia Nervosa
A NA study of Anorexia Nervosa and Bulimia Nervosa, sponsored by Yeshiva University.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT05753410: Completed NA study of Anorexia Nervosa and Bulimia Nervosa, sponsored by Yeshiva University.
NCT05753410 is a NA study of Anorexia Nervosa and Bulimia Nervosa that has completed, run by Yeshiva University. The registered enrollment target is 32 participants, below the 949-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05753410, a NA study of Anorexia Nervosa and Bulimia Nervosa, has completed, sponsored by Yeshiva University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
We will evaluate the acceptability and feasibility of a 8-week long digital mindfulness-based intervention for anorexia nervosa and bulimia nervosa. This study is a prospective single-arm trial during the intervention development phase. Following this phase, after the intervention has been further developed, a subsequent study (with a different clinicaltrials.gov identification #) will utilize a randomized control trial design.
Primary Outcome
Module completion, ranging from 0 to 100%
Conditions Studied
Interventions
- BEHAVIORAL Mindful Courage
Study Locations (1)
New York
- Margaret Sala - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2025-01-01 |
| Phase | NA |
What the finished NCT05753410 record still lists
NCT05753410 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 949-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Anorexia Nervosa appearing as the primary indexed condition, and to 1 intervention - of which Mindful Courage is the first listed.
NCT05753410 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05753410 about?
NCT05753410 is a clinical study titled "App-Based Mindfulness Training for Individuals With Anorexia Nervosa and Bulimia Nervosa". We will evaluate the acceptability and feasibility of a 8-week long digital mindfulness-based intervention for anorexia nervosa and bulimia nervosa. This study is a prospective single-arm trial during the intervention development phase. Following this phase, after the intervention has been further ...
What is the current status of trial NCT05753410?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2023-03-01. Estimated completion is 2025-01-01.
What conditions does trial NCT05753410 study?
This clinical trial studies the following conditions: Anorexia Nervosa, Bulimia Nervosa, Anorexia Nervosa, Atypical, Bulimia; Atypical.
What interventions are being tested in trial NCT05753410?
The interventions under investigation include: Mindful Courage (BEHAVIORAL).
Who is sponsoring clinical trial NCT05753410?
This trial is sponsored by Yeshiva University, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05753410 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anorexia Nervosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05753410's enrollment target sits among peer trials
32 28th of 43 higher than 15 of 43 other Anorexia Nervosa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anorexia Nervosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Diet for Relapse Prevention in Anorexia Nervosa
RECRUITING · NA
-
Facing Eating Disorder Fears for Anorexia Nervosa
RECRUITING · NA
-
Therapeutic Ketogenic Diet in Anorexia Nervosa
RECRUITING · NA
-
Confirming the Effectiveness of Online Guided Self-Help Family-Based Treatment for Adolescent Anorexia Nervosa
RECRUITING · NA
-
Targeting Social Function in Anxiety and Eating Disorders
RECRUITING · NA
-
Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI